{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:19:23Z","timestamp":1791253163882,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.lpm.2010.09.023","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T04:49:52Z","timestamp":1290574192000},"page":"173-184","source":"Crossref","is-referenced-by-count":52,"title":["Traitement des leishmanioses en France\u00a0: proposition d\u2019un r\u00e9f\u00e9rentiel consensuel"],"prefix":"10.1016","volume":"40","author":[{"given":"Pierre A.","family":"Buffet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gangneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Lightburne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Couppi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Morizot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lachaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Dedet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2010.09.023_bib0005","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2004.06226.x","article-title":"Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana","volume":"151","author":"Couppie","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0010","author":"Marty","year":"2009","journal-title":"Actualit\u00e9s sur les leishmanioses en France Arch Pediatr"},{"key":"10.1016\/j.lpm.2010.09.023_bib0015","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1128\/JCM.42.9.4077-4082.2004","article-title":"Isoenzymatic analysis of 712\u00a0strains of Leishmania infantum in the south of France and relationship of enzymatic polymorphism to clinical and epidemiological features","volume":"42","author":"Pratlong","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0020","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-3156.2009.02336.x","article-title":"Geographical distribution and epidemiological features of Old World cutaneous leishmaniasis foci, based on the isoenzyme analysis of 1048\u00a0strains","volume":"14","author":"Pratlong","year":"2009","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.lpm.2010.09.023_bib0025","doi-asserted-by":"crossref","unstructured":"Morizot G, Delgiudice P, Caumes E, Laffitte E, Marty P, Dupuy A, et al. Healing of Old World cutaneous leishmaniasis in travellers treated with fluconazole: drug effect or spontaneous evolution? Am J Trop Med Hyg 2007:76;48\u201352.","DOI":"10.4269\/ajtmh.2007.76.48"},{"key":"10.1016\/j.lpm.2010.09.023_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4269\/ajtmh.1990.43.25","article-title":"Cutaneous leishmaniasis in French Guiana: a review","volume":"43","author":"Dedet","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lpm.2010.09.023_bib0035","first-page":"1477","article-title":"Tolerance and pharmacokinetics of antimony in a patient with renal failure","volume":"10","author":"Buffet","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2010.09.023_bib0040","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"Navin","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0045","first-page":"503","article-title":"Traitement de la leishmaniose cutan\u00e9e localis\u00e9e","volume":"121","author":"Buffet","year":"1994","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0050","first-page":"2057","article-title":"Traitement de la leishmaniose visc\u00e9rale\u00a0: modalit\u00e9s r\u00e9centes","volume":"28","author":"Gangneux","year":"1999","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2010.09.023_bib0055","first-page":"257","article-title":"Traitement de la leishmaniose visc\u00e9rale\u00a0: le point sur l\u2019int\u00e9r\u00eat et les limites de la milt\u00e9fosine","volume":"11","author":"Gangneux","year":"2001","journal-title":"Sante"},{"key":"10.1016\/j.lpm.2010.09.023_bib0060","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1517\/14656566.3.8.1101","article-title":"Treatment of visceral leishmaniasis: a review of current treatment practices","volume":"3","author":"Marty","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.lpm.2010.09.023_bib0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/0022-3859.926","article-title":"Recent understanding in the treatment of visceral leishmaniasis","volume":"49","author":"Rosenthal","year":"2003","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.lpm.2010.09.023_bib0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00001432-200310000-00005","article-title":"Current treatment approaches to leishmaniasis","volume":"16","author":"Berman","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-308X(05)61006-8","article-title":"Chemotherapy in the treatment and control of leishmaniasis","volume":"61","author":"Alvar","year":"2006","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0080","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4269\/ajtmh.2009.80.939","article-title":"Drug hypersensitivity syndrome induced by meglumine antimoniate","volume":"80","author":"Jeddi","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lpm.2010.09.023_bib0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2005.72.133","article-title":"Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis","volume":"72","author":"Andersen","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lpm.2010.09.023_bib0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10\u00a0years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.lpm.2010.09.023_bib0095","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14728210903153862","article-title":"Developments in the treatment of visceral leishmaniasis","volume":"14","author":"den Boer","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.lpm.2010.09.023_bib0100","doi-asserted-by":"crossref","unstructured":"Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW. Single-dose liposomal amphotericin B for visceral leishmaniasis in India. N Engl J Med 2010;362:504\u201312.","DOI":"10.1056\/NEJMoa0903627"},{"key":"10.1016\/j.lpm.2010.09.023_bib0105","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.medmal.2009.05.001","article-title":"Le traitement de la leishmaniose visc\u00e9rale en Europe en 2009. Place de l\u2019amphotericine B liposomale","volume":"39","author":"Rosenthal","year":"2009","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.lpm.2010.09.023_bib0110","doi-asserted-by":"crossref","unstructured":"Berman J, Bryceson AD, Croft S, Engel J, Gutteridge W, Karbwang J, et al. Miltefosine: issues to be addressed in the future. Trans R Soc Trop Med Hyg 2006; 100\u00a0Suppl 1:S41\u201344.","DOI":"10.1016\/j.trstmh.2006.02.009"},{"key":"10.1016\/j.lpm.2010.09.023_bib0115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/519690","article-title":"Phase 4\u00a0trial of miltefosine for the treatment of Indian visceral leishmaniasis","volume":"196","author":"Bhattacharya","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0120","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for Visceral leishmaniasis in India","volume":"356","author":"Sundar","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.09.023_bib0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4269\/ajtmh.1994.50.107","article-title":"Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine","volume":"50","author":"Soto","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lpm.2010.09.023_bib0130","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-3156.2009.02329.x","article-title":"Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases","volume":"14","author":"Patel","year":"2009","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.lpm.2010.09.023_bib0135","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0140","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(05)70296-6","article-title":"Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004","volume":"5","author":"Olliaro","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0145","doi-asserted-by":"crossref","unstructured":"Bourgeois N, Bastien P, Reynes J, Makinson A, Rouanet I, Lachaud L.\u00a0\u2019Active chronic visceral leishmaniasis\u2019 in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10\u00a0patients. HIV Med 2010;11:670\u20133.","DOI":"10.1111\/j.1468-1293.2010.00846.x"},{"key":"10.1016\/j.lpm.2010.09.023_bib0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4269\/ajtmh.2009.81.209","article-title":"AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient","volume":"81","author":"de Valliere","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lpm.2010.09.023_bib0155","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1086\/497338","article-title":"Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2\u00a0patients with AIDS","volume":"192","author":"Posada-Vergara","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0160","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/506572","article-title":"First case of cutaneous reconstitution inflammatory syndrome associated with HIV infection and leishmaniasis","volume":"43","author":"Kerob","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0165","first-page":"383","article-title":"La leishmaniose cutan\u00e9e en France\u00a0: vers la fin des traitements injectables ?","volume":"96","author":"Buffet","year":"2003","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1016\/j.lpm.2010.09.023_bib0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-9292-6-3","article-title":"Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13\u201315\u00a0June, 2006","volume":"6","author":"Modabber","year":"2007","journal-title":"Kinetoplastid Biol Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1708-8305.2008.00286.x","article-title":"Treatment of cutaneous leishmaniasis in travelers 2009","volume":"16","author":"Blum","year":"2009","journal-title":"J Travel Med"},{"key":"10.1016\/j.lpm.2010.09.023_bib0180","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jac\/dkg356","article-title":"Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study","volume":"52","author":"Laguna","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.lpm.2010.09.023_bib0185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1179\/000349803225002606","article-title":"Treatment of leishmaniasis in HIV-positive patients","volume":"97","author":"Laguna","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0190","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1097\/00002030-200012220-00020","article-title":"Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy","volume":"14","author":"Berenguer","year":"2000","journal-title":"Aids"},{"key":"10.1016\/j.lpm.2010.09.023_bib0195","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/jac\/dkh084","article-title":"Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients","volume":"53","author":"Lopez-V\u00e9lez","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lpm.2010.09.023_bib0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/QAI.0b013e318166af5d","article-title":"Long-term monitoring of visceral leishmaniasis in patients with AIDS: relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis","volume":"48","author":"Bourgeois","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.lpm.2010.09.023_bib0205","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/AAC.42.8.2141","article-title":"Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis","volume":"42","author":"Durand","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lpm.2010.09.023_bib0210","doi-asserted-by":"crossref","unstructured":"Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, Ouellette M.\u00a0Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1\u00a0and Leishmania infantum. Clin Infect Dis 2009;48:e16\u201322.","DOI":"10.1086\/595710"},{"key":"10.1016\/j.lpm.2010.09.023_bib0215","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","article-title":"Liposomal amphotericin B for the treatment of visceral leishmaniasis","volume":"43","author":"Bern","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0220","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3201\/eid0912.030178","article-title":"Visceral leishmaniasis treatment","volume":"9","author":"Gradoni","year":"2003","journal-title":"Italy. Emerg Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0225","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1365-3156.2008.02144.x","article-title":"Drug regimens for visceral leishmaniasis in Mediterranean countries","volume":"13","author":"Gradoni","year":"2008","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.lpm.2010.09.023_bib0230","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1086\/367843","article-title":"Two doses of a lipid formulation of amphotericin B for the treatment of Mediterranean visceral leishmaniasis","volume":"36","author":"Syriopoulou","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0235","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.revmed.2007.03.048","article-title":"B liposomale en cure courte dans le traitement de la leishmaniose visc\u00e9rale m\u00e9diterran\u00e9enne de l\u2019adulte non immunod\u00e9prim\u00e9","volume":"28","author":"Jeandel","year":"2007","journal-title":"Rev de Mede Interne"},{"key":"10.1016\/j.lpm.2010.09.023_bib0240","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A policy for leishmaniasis with respect to the prevention and control of drug resistance","volume":"6","author":"Bryceson","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.lpm.2010.09.023_bib0245","first-page":"389","article-title":"Drug unresponsiveness & combination therapy for kala-azar","volume":"123","author":"Jha","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.lpm.2010.09.023_bib0250","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/591972","article-title":"New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine","volume":"47","author":"Sundar","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0255","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","article-title":"Treatment of cutaneous leishmaniasis among travellers","volume":"53","author":"Blum","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lpm.2010.09.023_bib0260","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major","volume":"346","author":"Alrajhi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.09.023_bib0265","doi-asserted-by":"crossref","unstructured":"Ben Salah A, Buffet PA, Morizot G, Ben Massoud N, Z\u00e2atour A, Ben Alaya N, et al. WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study. PLoS Negl Trop Dis 2009; 3:e432.","DOI":"10.1371\/journal.pntd.0000432"},{"key":"10.1016\/j.lpm.2010.09.023_bib0270","doi-asserted-by":"crossref","unstructured":"Gonzalez U, Pinart M, Reveiz L, Alvar J.\u00a0Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev 2008:CD005067.","DOI":"10.1002\/14651858.CD005067.pub3"},{"key":"10.1016\/j.lpm.2010.09.023_bib0275","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1128\/JCM.02555-06","article-title":"Detection and identification of Leishmania species from clinical specimens by using a real-time PCR assay and sequencing of the cytochrome B gene","volume":"45","author":"Foulet","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","article-title":"Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0285","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1179\/000349803225001373","article-title":"The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis","volume":"97","author":"Asilian","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0290","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.annder.2008.09.016","article-title":"Traitement de la leishmaniose cutan\u00e9e par cryoth\u00e9rapie associ\u00e9e ou non au Glucantime intra l\u00e9sionnel","volume":"136","author":"Chaabane","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0295","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-4362.1990.tb03759.x","article-title":"Cutaneous leishmaniasis. Treatment with combined cryotherapy and intralesional stibogluconate injection","volume":"29","author":"el Darouti","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0300","first-page":"169","article-title":"Efficacy of cryotherapy and intralesional pentostam in treatment of cutaneous leishmaniasis","volume":"30","author":"Gurei","year":"2000","journal-title":"J Egypt Soc Parasitol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0305","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4269\/ajtmh.2006.75.270","article-title":"Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapy","volume":"75","author":"Van Der Vliet","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lpm.2010.09.023_bib0310","first-page":"109","article-title":"Amato Neto V","volume":"47","author":"Tuon","year":"2008","journal-title":"Treatment of New World cutaneous leishmaniasis - a systematic review with a meta-analysis. Int J Dermatol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0315","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1371\/journal.pntd.0000381","article-title":"Paromomycin an Effective and Safe Treatment against Cutaneous Leishmaniasis? A meta-analysis of 14\u00a0randomized controlled trials","volume":"3","author":"Kim","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0320","doi-asserted-by":"crossref","unstructured":"Lecoeur H, Buffet P, Morizot G, Goyard S, Guigon G, Milon G, et al. Optimization of topical therapy for Leishmania major localized cutaneous Leishmaniasis using a reliable C57BL\/6\u00a0model. PLoS Negl Trop Dis 2007; 1:e34.","DOI":"10.1371\/journal.pntd.0000034"},{"key":"10.1016\/j.lpm.2010.09.023_bib0325","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1128\/AAC.01310-09","article-title":"Early curative applications of aminoglycosides (WR279396) on experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity","volume":"54","author":"Lecoeur","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lpm.2010.09.023_bib0330","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2230.2006.02182.x","article-title":"Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial","volume":"31","author":"Asilian","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0335","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0035-9203(91)90026-U","article-title":"A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis","volume":"85","author":"Harms","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.lpm.2010.09.023_bib0340","doi-asserted-by":"crossref","unstructured":"Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M. Unresponsiveness to glucantime treatment in Iranian cutaneous Leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med 2006; 3:e162.","DOI":"10.1371\/journal.pmed.0030162"},{"key":"10.1016\/j.lpm.2010.09.023_bib0345","first-page":"418","article-title":"Treatment of tegumentary leishmaniasis with pentamidine in French Guyana","volume":"54","author":"Pradinaud","year":"1994","journal-title":"Med Trop"},{"key":"10.1016\/j.lpm.2010.09.023_bib0350","first-page":"35","article-title":"Th\u00e9rapeutique des leishmanioses t\u00e9gumentaires du Nouveau Monde. Exp\u00e9rience \u00e0 propos de 326\u00a0cas trait\u00e9s par is\u00e9thionate de pentamidine \u00e0 fortes doses","volume":"63","author":"Lightburn","year":"2003","journal-title":"Med Trop"},{"key":"10.1016\/j.lpm.2010.09.023_bib0355","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/00034980120064355","article-title":"Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana","volume":"95","author":"Nacher","year":"2001","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0360","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1179\/136485906X105561","article-title":"Comparison between one and two injections of pentamidine isethionate, at 7mg\/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana","volume":"100","author":"Roussel","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0365","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0399-077X(05)81436-2","article-title":"Traitement de la l\u00e9sion cutan\u00e9e primaire de la leishmaniose \u00e0 Leishmania braziliensis\u00a0: \u00e9chec de l\u2019is\u00e9thionate de pentamidine","volume":"22","author":"Dimier-David","year":"1992","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.lpm.2010.09.023_bib0370","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11908-005-0021-1","article-title":"Recent developments in Leishmaniasis: epidemiology diagnosis, and treatment","volume":"7","author":"Berman","year":"2005","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.lpm.2010.09.023_bib0375","first-page":"209","article-title":"Traitement par amphot\u00e9ricine B liposomale d\u2019une leishmaniose cutan\u00e9e contract\u00e9e \u00e0 Djibouti et r\u00e9sistante \u00e0 l\u2019antimoniate de m\u00e9glumine","volume":"96","author":"Rapp","year":"2003","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1016\/j.lpm.2010.09.023_bib0380","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2133.2005.06670.x","article-title":"Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis","volume":"153","author":"Brown","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2010.09.023_bib0385","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2001.65.456","article-title":"Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate","volume":"65","author":"Romero","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lpm.2010.09.023_bib0390","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0395","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala","volume":"65","author":"Arana","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lpm.2010.09.023_bib0400","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4269\/ajtmh.1994.51.77","article-title":"Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis","volume":"51","author":"Franke","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lpm.2010.09.023_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2007.08.003","article-title":"Mucosal leishmaniasis. Current scenario and prospects for treatment","volume":"105","author":"Amato","year":"2008","journal-title":"Acta Trop"},{"key":"10.1016\/j.lpm.2010.09.023_bib0410","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/511643","article-title":"Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis","volume":"44","author":"Machado","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0415","first-page":"339","article-title":"Rural campaign to diagnose and treat mucocutaneous leishmaniasis in Bolivia","volume":"73","author":"Dedet","year":"1995","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.lpm.2010.09.023_bib0420","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4269\/ajtmh.2009.81.387","article-title":"Efficacy of extended (six weeks) treatment with miltefosine for mucosal leishmaniasis in Bolivia","volume":"81","author":"Soto","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lpm.2010.09.023_bib0425","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/510588","article-title":"Treatment of Bolivian mucosal leishmaniasis with miltefosine","volume":"44","author":"Soto","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0430","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/510494","article-title":"Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B","volume":"44","author":"Amato","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2010.09.023_bib0435","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1590\/S0037-86821997000200007","article-title":"Tratamento da forma mucosa de leishmaniose sem resposta a glucantime, com anfortericina B liposomal","volume":"30","author":"Sampaio","year":"1997","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.lpm.2010.09.023_bib0440","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0035-9203(03)90109-X","article-title":"Leishmania major and HIV co-infection in Burkina Faso","volume":"97","author":"Guiguemde","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498210005713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498210005713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:10:05Z","timestamp":1740701405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498210005713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0755498210005713"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2010.09.023","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}